All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Bookmark this article
Philippe Armand and Roch Houot share information related to the recently launched COVID-HEME initiative including how hematologists can get involved.
COVID-HEME is a peer-to-peer forum for physicians about the care of patients with hematologic malignancies during the COVID-19 pandemic. The goal of this collaborative platform is to improve and accelerate the knowledge and experience of physicians to optimize the management of patients during the pandemic.
To join COVID-HEME, please ask for an invitation at firstname.lastname@example.org
COVID-HEME forum supports hematologists during COVID-19 pandemic
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Predictive factors of mortality in patients with hematological malignancies diagnosed with COVID-19
During this COVID-19 pandemic, patients with hematological malignancies—who are immunocompromised because of the cancer itself, immunosuppressive...
The effect of COVID-19 on the management of patients with lymphoma
A summary of recommendations for patients with lymphoma during the COVID-19 pandemic provided by Executive Steering Committee Member Stefano Luminari.
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox